Yonghe Medical (02279.HK) announced its interim performance for the six months ended in June, with revenue recorded at 0.9 billion RMB (same below), an 8.7% year-on-year increase. The loss narrowed from 0.226 billion yuan in the same period last year to 0.139 billion yuan, with a loss per share of 28 fen. No interim dividend will be distributed.
《業績》雍禾醫療(02279.HK)中期虧損收窄至1.39億人民幣
《Performance》Yonghe Medical (02279.HK) narrowed its interim loss to 0.139 billion RMB.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated